Last reviewed · How we verify
Treatment Algorithm C
At a glance
| Generic name | Treatment Algorithm C |
|---|---|
| Also known as | vedolizumab |
| Sponsor | Alimentiv Inc. |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer (PHASE2)
- Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia (NA)
- A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept (NA)
- Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System
- BLOOM: Pragmatic Feasibility Trial (NA)
- Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium (NA)
- Determination of the Optimal Treatment Target in Ulcerative Colitis (PHASE4)
- Collaborative Quality Improvement (C-QIP) Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |